GOLDSMITH MARK A 4

4 · Revolution Medicines, Inc. · Filed Mar 3, 2026

Insider Transaction Report

Form 4

Period: 2026-03-01

Revolution Medicines, Inc.RVMD

GOLDSMITH MARK A

DirectorSee Remarks

Transactions

Award
Common Stock
[F1][F2]
2026-03-01+57,100→ 289,569 total
Exercise/Conversion
Common Stock
[F3][F1]
2026-03-02$4.09/sh+30,000$122,700→ 319,569 total
Sale
Common Stock
[F3][F4][F1]
2026-03-02$98.17/sh−700$68,720→ 318,869 total
Sale
Common Stock
[F3][F5][F1]
2026-03-02$99.76/sh−3,500$349,150→ 315,369 total
Sale
Common Stock
[F3][F6][F1]
2026-03-02$100.73/sh−3,620$364,659→ 311,749 total
Sale
Common Stock
[F3][F7][F1]
2026-03-02$101.60/sh−21,329$2,167,075→ 290,420 total
Sale
Common Stock
[F3][F8][F1]
2026-03-02$102.20/sh−851$86,972→ 289,569 total
Sale
Common Stock
[F10]
2026-03-02$98.31/sh−100$9,831→ 67,324 total(indirect: By Trust)
Sale
Common Stock
[F11][F10]
2026-03-02$100.12/sh−400$40,049→ 66,924 total(indirect: By Trust)
Sale
Common Stock
[F12][F10]
2026-03-02$101.47/sh−1,700$172,506→ 65,224 total(indirect: By Trust)
Sale
Common Stock
[F13][F10]
2026-03-02$102.00/sh−800$81,599→ 64,424 total(indirect: By Trust)
Sale
Common Stock
[F14]
2026-03-02$98.29/sh−100$9,829→ 67,324 total(indirect: By Trust)
Sale
Common Stock
[F15][F14]
2026-03-02$100.19/sh−600$60,116→ 66,724 total(indirect: By Trust)
Sale
Common Stock
[F16][F14]
2026-03-02$101.63/sh−2,100$213,432→ 64,624 total(indirect: By Trust)
Sale
Common Stock
[F14]
2026-03-02$102.08/sh−200$20,416→ 64,424 total(indirect: By Trust)
Award
Stock Option (Right to Buy)
[F17]
2026-03-01+128,600→ 128,600 total
Exercise: $102.02Exp: 2036-02-28→ Common Stock (128,600 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
[F1]
2026-03-02−30,000→ 47,708 total
Exercise: $4.09From: 2023-03-13Exp: 2029-03-12→ Common Stock (30,000 underlying)

Holdings

Common Stock
[F2][F9]
(indirect: By Trust)
594,060

Footnotes (17)

[F1]Includes 225,863 restricted stock units.
[F10]Held by Jonathan Goldsmith Revocable Trust.
[F11]This transaction was executed in multiple trades at prices ranging from $99.79 to $100.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F12]This transaction was executed in multiple trades at prices ranging from $100.81 to $101.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F13]This transaction was executed in multiple trades at prices ranging from $101.82 to $102.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F14]Held by Rebecca Goldsmith Revocable Trust.
[F15]This transaction was executed in multiple trades at prices ranging from $99.80 to $100.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F16]This transaction was executed in multiple trades at prices ranging from $101.07 to $102.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F17]One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
[F2]Reflects the transfer of 24,010 shares to the Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
[F3]Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.
[F4]This transaction was executed in multiple trades at prices ranging from $97.83 to $98.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F5]This transaction was executed in multiple trades at prices ranging from $99.12 to $100.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F6]This transaction was executed in multiple trades at prices ranging from $100.14 to $101.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F7]This transaction was executed in multiple trades at prices ranging from $101.14 to $102.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F8]This transaction was executed in multiple trades at prices ranging from $102.14 to $102.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F9]Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.

Signature

/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith|2026-03-03

Documents

1 file

4
form4.xmlPrimary